Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: A long-term follow-up study

Cancer

Volumn 118, Issue 6, 2012, Pages 1693-1700

  Liu, Wei ^a   Feng, Jin Qiu ^a,b   Shen, Xue Min ^a   Wang, Hai Yan ^a   Liu, Yang ^a   Zhou, Zeng Tong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Municipal Hospital for Oral Health   (China)

Author keywords

ATP binding cassette; BMI 1; G2 subfamily (ABCG2); leukoplakia; malignant transformation; oral cancer; stem cell marker

Indexed keywords

BMI1 PROTEIN; BREAST CANCER RESISTANCE PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STEM CELL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; METASTASIS FREE SURVIVAL; MOLECULAR PATHOLOGY; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOPLAKIA, ORAL; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES;

EID: 84857995376     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26483     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96. (Pubitemid 351521864)
2. Neville BW, Day TA,. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002; 52: 195-215.
3. van der Waal I, Schepman KP, van der Meij EH, Smeele LE,. Oral leukoplakia: a clinicopathological review. Oral Oncol. 1997; 33: 291-301. (Pubitemid 28129229)
4. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E,. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med. 1995; 24: 198-200.
5. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 80: 188-191.
6. Kujan O, Khattab A, Oliver RJ, Roberts SA, Thakker N, Sloan P,. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol. 2007; 43: 224-231. (Pubitemid 46228016)
7. Ho PS, Chen PL, Warnakulasuriya S, Shieh TY, Chen YK, Huang IY,. Malignant transformation of oral potentially malignant disorders in males: a retrospective cohort study. BMC Cancer. 2009; 9: 260.
8. World Health Organization. World Health Organization international histological classification of tumors. In:, Pindborg JJ, Reichart PA, Smith CJ, Van der Waal I, eds. Histological typing of Cancer and Precancer of the Oral Mucosa. Berlin: Springer; 1997: 25-30.
9. Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001; 7: 1028-1034. (Pubitemid 32937383)
10. Ho MM, Ng AV, Lam S, Hung JY,. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007; 67: 4827-4833. (Pubitemid 46910191)
11. Huang D, Gao Q, Guo L, et al. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev. 2009; 18: 465-473.
12. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH,. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 2007; 67: 3716-3724. (Pubitemid 46762157)
13. Zhang P, Zhang Y, Mao L, Zhang Z, Chen W,. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009; 277: 227-234.
14. Zen Y, Fujii T, Yoshikawa S, et al. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma. Am J Pathol. 2007; 170: 1750-1762. (Pubitemid 47339318)
15. Tsunoda S, Okumura T, Ito T, et al. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology. 2006; 71: 251-258.
16. Diestra JE, Scheffer GL, Catala L, et al. Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol. 2002; 198: 213-219. (Pubitemid 35243879)
17. Sparmann A, van Lohuizen M,. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006; 6: 846-856. (Pubitemid 44629896)
18. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007; 104: 973-978. (Pubitemid 46154721)
19. Chen YC, Chang CJ, Hsu HS, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol. 2010; 46: 158-165.
20. Ganguli-Indra G, Wasylyk C, Liang X, et al. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status. PLoS One. 2009; 4: e5367.
21. Vrzalikova K, Skarda J, Ehrmann J, et al. Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol. 2008; 134: 1037-1042.
22. Liu JH, Song LB, Zhang X, et al. Bmi-1 expression predicts prognosis for patients with gastric carcinoma. J Surg Oncol. 2008; 97: 267-272. (Pubitemid 351312168)
23. Huber GF, Albinger-Hegyi A, Soltermann A, et al. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma [published online ahead of print March 29, 2011]. Cancer. doi: 10.1002/cncr.26100.
24. Song LB, Zeng MS, Liao WT, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006; 66: 6225-6232.
25. Hayry V, Makinen LK, Atula T, et al. Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. Br J Cancer. 2010; 102: 892-897.
26. Tateishi K, Ohta M, Kanai F, et al. Dysregulated expression of stem cell factor Bmi-1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res. 2006; 23: 6960-6966. (Pubitemid 44974489)
27. Kang MK, Kim RH, Kim SJ, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 2007; 96: 126-133. (Pubitemid 46094649)
28. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, et al. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol. 2008; 26: 354-360. (Pubitemid 351171684)
29. Shi P, Liu W, Zhou ZT, He QB, Jiang WW,. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Cancer Epidemiol Biomarkers Prev. 2010; 19: 844-849.
30. Vormittag L, Thurnher D, Geleff S, et al. Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys. 2009; 73: 913-918.
31. Tokar EJ, Diwan BA, Waalkes MP,. Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype. Environ Health Perspect. 2010; 118: 108-115.
32. Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY,. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010; 10: 685.
33. Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008; 14: 4085-4095.
34. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K,. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009; 45: 633-639.
35. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000; 6: 357-362. (Pubitemid 30111451)
36. Montebugnoli L, Cervellati F, Cocchi R, et al. Immunohistochemical expression of p16(INK4A) protein as a helpful marker of a subset of potentially malignant oral epithelial lesions: study on a series with long-term follow-up. Histopathology. 2010; 57: 528-534.
37. Ogbureke KU, Abdelsayed RA, Kushner H, Li L, Fisher LW,. Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. Cancer. 2010; 116: 1709-1717.
38. Lodi GSA, Sardella A, Bez C, Demarosi F, Carrassi A,. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006;(4): CD001829.